Evelo Biosciences (EVLO) Short Interest Ratio & Short Volume $0.0005 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Evelo Biosciences Short Interest DataEvelo Biosciences (EVLO) has a short interest of 6,700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 8.4, indicating that it would take 8.4 days of the average trading volume of 10,810 shares to cover all short positions.Current Short Interest6,700 sharesPrevious Short Interest6,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.35Short Interest Ratio8.4 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares18,983,000 sharesPercentage of Shares Shorted0.04%Today's Trading Volume0 sharesAverage Trading Volume10,810 sharesToday's Volume Vs. Average0% Short Selling Evelo Biosciences? Sign up to receive the latest short interest report for Evelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVLO Short Interest Over TimeEVLO Days to Cover Over TimeEVLO Percentage of Float Shorted Over Time Evelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20256,700 shares $3.35 No ChangeN/A8.4 $0.00 6/30/20256,700 shares $3.35 No Change0.0%9.6 $0.00 6/15/20256,700 shares $3.35 No Change0.0%0.3 $0.00 5/31/20256,700 shares $2.68 No Change0.0%1 $0.00 5/15/20256,700 shares $2.01 No ChangeN/A4.2 $0.00 4/30/20256,700 shares $3.35 No ChangeN/A33.5 $0.00 4/15/20256,700 shares $3.35 No ChangeN/A6.1 $0.00 3/14/20256,700 shares $3.35 No ChangeN/A16.8 $0.00 2/28/20256,700 shares $16.75 No ChangeN/A67 $0.00 2/14/20256,700 shares $3.35 -1.5%N/A2.2 $0.00 Get the Latest News and Ratings for EVLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20256,800 shares $3.40 No ChangeN/A0.2 $0.00 1/15/20256,800 shares $3.40 No ChangeN/A8.5 $0.00 11/30/2023197,000 shares $78.82 thousand -54.2%2.1%0.3 $0.40 11/15/2023430,100 shares $191.48 thousand +175.0%4.6%0.6 $0.45 10/31/2023156,400 shares $64.28 thousand -76.6%1.7%0.4 $0.41 10/15/2023667,800 shares $2.08 million +13.9%7.2%2.6 $3.12 9/30/2023586,400 shares $2.30 million +119.1%6.3%1.1 $3.92 9/15/2023267,700 shares $1.36 million -3.8%2.9%0.4 $5.07 8/31/2023278,200 shares $1.84 million -10.8%3.0%0.3 $6.61 8/15/2023312,000 shares $4.15 million -31.7%3.4%0.4 $13.31 7/31/2023456,600 shares $4.78 million +123.0%4.9%0.6 $10.47 7/15/2023204,800 shares $739.33 thousand -47.3%2.2%0.2 $3.61 6/30/2023388,300 shares $25.24 million -78.4%13.9%0.7 $65.00 6/15/20231,800,000 shares $149.22 thousand -41.6%N/A0.2 $0.08 5/31/20233,080,000 shares $420.42 thousand -13.7%N/A0.8 $0.14 5/15/20233,570,000 shares $505.51 thousand +58.7%N/A1 $0.14 4/30/20232,250,000 shares $346.05 thousand -10.0%N/A0.6 $0.15 4/15/20232,500,000 shares $418.25 thousand -15.8%N/A7.6 $0.17 3/31/20232,970,000 shares $536.68 thousand +3.9%N/A10.6 $0.18 3/15/20232,860,000 shares $900.90 thousand +4.4%N/A18.1 $0.32 2/28/20232,740,000 shares $1.70 million -22.2%N/A20.7 $0.62 2/15/20233,520,000 shares $2.83 million -21.4%N/A26.5 $0.81 1/31/20234,480,000 shares $4.66 million No ChangeN/A33.8 $1.04 1/15/20234,480,000 shares $6.18 million +2.5%N/A38.5 $1.38 12/30/20224,370,000 shares $7.04 million -1.8%N/A41 $1.61 12/15/20224,450,000 shares $8.23 million +0.5%N/A44.3 $1.85 11/30/20224,430,000 shares $9.26 million -0.7%N/A29 $2.09 11/15/20224,460,000 shares $9.77 million +0.2%8.5%28.6 $2.19 10/31/20224,450,000 shares $9.08 million No ChangeN/A30.6 $2.04 10/15/20224,450,000 shares $9.57 million -2.2%N/A34.1 $2.15Elon’s Secret Social Security Bombshell (Ad)To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.A major government announcement coming as soon as tomorrow. 9/30/20224,550,000 shares $9.51 million +13.2%N/A32.5 $2.09 9/15/20224,020,000 shares $8.52 million -1.0%N/A18.8 $2.12 8/31/20224,060,000 shares $8.89 million +2.0%N/A18.9 $2.19 8/15/20223,980,000 shares $10.95 million -3.6%N/A14.9 $2.75 7/31/20224,130,000 shares $8.71 million -1.2%N/A14 $2.11 7/15/20224,180,000 shares $9.20 million -4.1%N/A12.2 $2.20 6/30/20224,360,000 shares $9.20 million -23.9%N/A11.9 $2.11 6/15/20225,730,000 shares $10.43 million -22.5%N/A14.5 $1.82 5/31/20227,390,000 shares $15.52 million -8.1%N/A23.3 $2.10 5/15/20228,040,000 shares $13.27 million -4.2%29.5%26.3 $1.65 4/30/20228,390,000 shares $20.72 million -0.5%30.8%25.1 $2.47 4/15/20228,430,000 shares $21.41 million No Change31.5%25.2 $2.54 3/31/20228,430,000 shares $28.58 million +2.6%N/A0 $3.39 3/15/20228,220,000 shares $23.43 million +0.6%30.9%27.2 $2.85 2/28/20228,170,000 shares $25.57 million +10.0%30.7%28.3 $3.13 2/15/20227,430,000 shares $29.94 million +11.9%27.9%27.2 $4.03 1/31/20226,640,000 shares $31.27 million +6.8%25.0%28.8 $4.71 1/15/20226,220,000 shares $34.33 million +5.4%N/A24.6 $5.52 12/31/20215,900,000 shares $35.81 million +7.3%22.2%20.9 $6.07 12/15/20215,500,000 shares $42.68 million +6.6%20.7%15.5 $7.76 11/30/20215,160,000 shares $44.48 million -5.3%19.4%13.8 $8.62 11/15/20215,450,000 shares $55.97 million +4.2%20.5%14.5 $10.27 10/29/20215,230,000 shares $46.29 million -3.3%19.7%14.5 $8.85 10/15/20215,410,000 shares $43.01 million +11.8%20.4%17.2 $7.95 9/30/20214,840,000 shares $34.07 million +35.2%18.2%15.6 $7.04 9/15/20213,580,000 shares $25.02 million +12.2%13.5%15.7 $6.99 8/31/20213,190,000 shares $36.27 million -1.5%12.0%17.7 $11.37 8/13/20213,240,000 shares $33.66 million -10.5%12.2%18.2 $10.39 7/30/20213,620,000 shares $33.34 million +10.4%13.6%19.8 $9.21 7/15/20213,280,000 shares $36.08 million +19.7%12.4%17.6 $11.00 6/30/20212,740,000 shares $37.65 million +7.9%10.3%13.1 $13.74 6/15/20212,540,000 shares $41.53 million -2.7%9.6%14.1 $16.35 5/28/20212,610,000 shares $35.03 million -13.3%9.8%12.8 $13.42 5/14/20213,010,000 shares $33.14 million +13.6%11.3%13.4 $11.01 4/30/20212,650,000 shares $32.44 million +1.5%9.0%11.3 $12.24 4/15/20212,610,000 shares $29.10 million -17.9%N/A0 $11.15 3/31/20213,180,000 shares $32.98 million +8.2%12.2%11.5 $10.37 3/15/20212,940,000 shares $35.13 million +25.6%11.3%9.6 $11.95 2/26/20212,340,000 shares $31.94 million -11.0%10.3%5.6 $13.65 2/12/20212,630,000 shares $42.79 million +22.9%11.6%6.7 $16.27 1/29/20212,140,000 shares $39.80 million -14.1%9.4%5.5 $18.60 1/15/20212,490,000 shares $34.31 million +18.6%12.8%7.4 $13.78 12/31/20202,100,000 shares $25.33 million +5.0%14.2%6.3 $12.06 12/15/20202,000,000 shares $18.82 million -3.4%13.5%6.8 $9.41 11/30/20202,070,000 shares $10.76 million -0.5%14.0%14.1 $5.20 11/15/20202,080,000 shares $9.44 million +1.5%14.1%14 $4.54 10/30/20202,050,000 shares $8.90 million +7.3%13.9%13.7 $4.34 10/15/20201,910,000 shares $10.16 million +10.4%12.9%11.7 $5.32 9/30/20201,730,000 shares $9.12 million +19.3%11.7%11.1 $5.27 9/15/20201,450,000 shares $7.66 million +5.1%9.8%8.2 $5.28Elon’s Secret Social Security Bombshell (Ad)To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.A major government announcement coming as soon as tomorrow. 8/31/20201,380,000 shares $6.13 million +16.0%9.3%8.2 $4.44 8/14/20201,190,000 shares $6.01 million +0.9%8.1%7.9 $5.05 EVLO Short Interest - Frequently Asked Questions What is Evelo Biosciences' current short interest? Short interest is the volume of Evelo Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 6,700 shares of EVLO short. Learn More on Evelo Biosciences' current short interest. What is a good short interest ratio for Evelo Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVLO shares currently have a short interest ratio of 8.0. Learn More on Evelo Biosciences's short interest ratio. How does Evelo Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evelo Biosciences: Syros Pharmaceuticals, Inc. (0.40%), Smart for Life, Inc. (0.01%), Scopus BioPharma Inc. (0.02%), Comera Life Sciences Holdings, Inc. (0.01%), Genocea Biosciences, Inc. (0.33%), Aridis Pharmaceuticals, Inc. (0.04%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), eFFECTOR Therapeutics, Inc. (0.12%), Clever Leaves Holdings Inc. (0.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Evelo Biosciences stock? Short selling EVLO is an investing strategy that aims to generate trading profit from Evelo Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evelo Biosciences? A short squeeze for Evelo Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVLO, which in turn drives the price of the stock up even further. How often is Evelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVLO, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Syros Pharmaceuticals Short Interest Smart for Life Short Interest Scopus BioPharma Short Interest Comera Life Sciences Short Interest Genocea Biosciences Short Interest Aridis Pharmaceuticals Short Interest Statera Biopharma Short Interest Ampio Pharmaceuticals Short Interest eFFECTOR Therapeutics Short Interest Clever Leaves Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVLO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVLO Stock Alerts